1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Cannabinoid Receptor
  4. CB2 Isoform

CB2

 

CB2 Related Products (31):

Cat. No. Product Name Effect Purity
  • HY-128872
    EHP-101
    Agonist 98.56%
    EHP-101 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist.
  • HY-100488
    Bay 59-3074
    Agonist 99.00%
    Bay 59-3074 is a selective cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors, respectively.
  • HY-W005629
    Leelamine
    Agonist 98.36%
    Leelamine is a weak agonist of cannabinoid receptors CB1 and CB2.
  • HY-13505
    AM281
    Antagonist ≥99.0%
    AM281 is a selective CB1 receptor antagonist with an IC50 of 9.91 nM.
  • HY-14900
    Tedalinab
    Inhibitor 99.94%
    Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist.
  • HY-152254
    CB2R/FAAH modulator-3
    Agonist
    CB2R/FAAH modulator-3 (compound 27) is a dual targeting modulator that acts as a CB2R agonist and FAAH inhibitor.
  • HY-150029
    CB1/2 agonist 3
    Agonist
    CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist.
  • HY-101765
    GW 833972A
    Agonist
    GW 833972A is a selective CB2 receptor agonist.
  • HY-119104
    AZD1940
    Agonist 99.45%
    AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively.
  • HY-W011040
    LY320135
    Antagonist
    LY320135 is a potent and selective antagonist of CB1 receptor, with a Ki of 141 nM.
  • HY-133533
    O-2050
    Antagonist
    O-2050 is a high affinity cannabinoid CB1 receptor antagonist with a Ki of 2.5 nM.
  • HY-110014
    Noladin ether
    Agonist
    Noladin ether is a potent and selective agonist of cannabinoid CB1 receptor, with a Ki of 21.2 nM.
  • HY-135419
    CB2 modulator 1
    Modulator
    CB2 modulator 1 (compound 130) is a potent CB2 modulator.
  • HY-14788
    Drinabant
    Antagonist
    Drinabant (AVE1625) is an orally active CB1 receptor antagonist.
  • HY-119744
    BAY 38-7271
    Agonist
    BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively.
  • HY-100328
    CB2R-IN-1
    Inhibitor
    CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM.
  • HY-132217
    CB2 receptor agonist 2
    Agonist
    CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM.
  • HY-146134
    PGN36
    Antagonist
    PGN36 (Compound 18) is a selective cannabinoid CB2 receptor (CB2R) antagonist with a Ki of 0.09 µM.
  • HY-131004
    CB2R PAM
    Agonist
    CB2R PAM is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator.
  • HY-147532
    CB2R probe 1
    CB2R probe 1 is a safe and green CB2R (cannabinoid 2 receptor) fluorescent probe with an Ki of 130 nM.